James F. Oliviero III, CEO, President and Director at Checkpoint Therapeutics, Inc. (CKPT), sold 30,180 shares at $4.04 ($122K) on 2025-04-02, disclosed to the SEC on 2025-04-03.
Open-market sale of $122k CKPT by CEO, President and Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.04 | 15,090 | $61K | 50.0% |
| 2 | $4.04 | 15,090 | $61K | 50.0% |
| Total | $4.04 avg | 30,180 | $122K | 100% |
| Filing → |
| CKPT | SELL | 2024-06-28 | $101K | — | Filing → |
| CKPT | SELL | 2024-03-01 | $12K | — | Filing → |
| CKPT | SELL | 2024-02-02 | $24K | — | Filing → |